Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.

about

The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy.

P2860

Q36342262-16EE809C-1CCA-495B-9A97-0EBAC102D5AD

P2860

Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.

Item

http://www.wikidata.org/entity/Q53594601

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Rosuvastatin for Reduction of ...... ngioplasty - the Remedy Trial.

@en

Rosuvastatin for Reduction of ...... ngioplasty - the Remedy Trial.

@nl

type

Item

label

Rosuvastatin for Reduction of ...... ngioplasty - the Remedy Trial.

@en

Rosuvastatin for Reduction of ...... ngioplasty - the Remedy Trial.

@nl

prefLabel

Rosuvastatin for Reduction of ...... ngioplasty - the Remedy Trial.

@en

Rosuvastatin for Reduction of ...... ngioplasty - the Remedy Trial.

@nl

P1476

Rosuvastatin for Reduction of ...... Angioplasty - the Remedy Trial

@en

P2093

Carlo Briguori

http://www.w3.org/2001/XMLSchema#string

Cristina Quintavalle

http://www.w3.org/2001/XMLSchema#string

Gerolama Condorelli

http://www.w3.org/2001/XMLSchema#string

Marco Zimarino

http://www.w3.org/2001/XMLSchema#string

Maria Salomone

http://www.w3.org/2001/XMLSchema#string

Paolo Calabrò

http://www.w3.org/2001/XMLSchema#string

Raffaele De Caterina

http://www.w3.org/2001/XMLSchema#string

P2860

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

Myonecrosis after revascularization procedures

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Cardioprotective actions of acute HMG-CoA reductase inhibition in the setting of myocardial infarction.

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers

Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport.

P304

465-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10557-016-6672-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rosalinda Madonna

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27358173

http://www.w3.org/2001/XMLSchema#string

Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.

about

P2860

P2860

Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698